Edgar Cristobal, our colleague from Miriam Royo’s CSIC group, presented valuable results from Smart4Fabry at the 6th Symposium of Medicinal Chemistry Young Researchers, organized by the Spanish Society of Therapeutic Chemistry (SEQT). This sixth edition was held in the facilities of GlaxoSmithKline España in Tres Cantos on June 21st, 2019.
As in former editions, this Symposium is aimed to give the opportunity to Post-doc, Pre-doc, Master’s degree, and Bachelor’s degree students to show and discuss their results in research fields as Medicinal Chemistry, Pharmacology, Organic Synthesis, Molecular Biology, Computational Chemistry, Chemical Biology, Natural Products, Biotechnology, Biochemistry and Crystallography.
Edgar gave a talk focused in the development and optimization of the construct Cholesterol-PEG-peptide.
Our colleague Judith Tomsen, PhD fellow at the Nanomol group, was awarded with the best oral presentation at the European Students Colloid Conference (ESC-2019), that took place in Varna (Bulgaria) on 18-22 June 2019. The European Colloids and Interfaces Society (ECIS) organizes biannually ESC meetings of advanced students at PhD and MSc level who are undertaking research in the area of colloid and interface science at a European University. These meetings are intended for students to present their work to their peers and to interact both scientifically and socially. Apart from a few invited senior lecturers, meetings are restricted to PhD students, who have not yet submitted their theses, and to MSc students. Judith presented a talk based on the results obtained in her research activities for Smart4Fabry project, obtaining the award that shows the great interest generated by her talk and project outcomes.
On the 6th of June the SMART4FABRY project hold its Steering Committee in Brussels. The partners decided to have an in person meeting due to the importance of the decision. We took the chance to use the kind invitation from our Scientific Project Officer, Heico Frima, to carry out the meeting at Covent Garden Building, hosted by the European Commission. It was also an excellent opportunity to show the project progress and plans for the next period to Mr. Frima.
“POST-WS RAREVIEW 2019, Innovation in lysosomal storage diseases” is the name of a high level Conference held in Madrid in April 2019. This meeting has joined more than 100 specialists from different clinical fields focused in lysosomal storage diseases, together with relevant stakeholders from the Pharmaceutical Industry. This forum mirrors, at a Spanish level, the 13th World Symposium Research for Lysosomal Diseases, were the project was also introduced by Ibane Abasolo. Smart4Fabry was represented by Dr Ibane Abasolo from CIBER/VHIR. This year, Dr Abasolo was invited to present a talk named “Targeted Nanoliposomes for the treatment of Fabry disease”, fully focused in the enhanced treatment for Fabry disease which is the main aim of Smart4Fabry project. This meeting has been again an excellent opportunity to introduce our project to clinicians and industrial partners, opening pathways for scientific collaboration and potential future exploitation agreements.
All rare diseases need to enhance their awareness and social visibility. April is the month which has been selected as the Fabry disease awareness month. Different initiatives will support this awareness campaign, especially in social media. The ribbon is the proposed symbol to be shared for this initiative. It has been developed by the National Fabry Disease Foundation (US)
“Personalized Medicines, Targeted Therapies, Precision Drug Delivery”
6th – 8th March, 2019, in Frankfurt am Main, Germany
From 6th to 8th March 2019, the Annual Meeting of the European Federation for Pharmaceutical Sciences (EUFEPS) took place at Goethe-University’s “Campus Riedberg” in the North of Frankfurt, Germany, hosted by the new EUFEPS President and Conference Chair Prof. Dr. Dieter Steinhilber. The EUFEPS Annual Meeting brought together people from all over the world who are involved in pharmaceutical sciences in order to exchange results, experiences and information, and to build communication and collaboration at regional and global scale. A broad range of sessions for oral and poster presentations covered important aspects of current pharmaceutical research. The event provided scientific sessions on the following topics:
BioNanoNet participated the conference and contributed a poster presentation on the H2020 project Smart-4-Fabry, addressing the following topic:
“Novel Lipid-based Nanoformulation for Treatment of Fabry Disease”, S. Resch, C. Schimpel, N. Ventosa, T. Birngruber, A. Falk.
BioNanoNet members Priv.-Doz. Dr. Frank Sinner from JOANNEUM RESEARCH – HEALTH and Prof. Dr. Johannes Khinast from RCPE gave insights into their latest research activities. The next EUFEPS Annual Meeting will take place from 15th to 17th June 2020 in Gothenburg, Sweden.
The project was present in Austria for the Rare Diseases day 2019. The presentation of the Smart4Fabry Project and the technology DELOS-SUSP was presented by Johanna and Santi Sala (respectively) in the frame of the “First Austrian Microfluidics Initiative Symposium” hold the 28th February in Viena. In this Symposium organized by TUWien, TUGraz, Univ. Salzburg and BioNanoNet, a specific session with title “Rare Disease Day 2019” was scheduled. In this session three presentations were hold: Smart4Fabry project, Nanomol Technologies and its DELOS Susp technology and the H2020-MSCA-RISE-2017 “CISTEM” project.
Smart4Fabry partners from CIBER-VHIR, led by Dr. Ibane Abasolo, had a relevant presence at WORLDSymposium, held in Orlando, Florida, 4-8 February 2019. WORLD (We are Organizing Research on Lysosomal Diseases) Symposium is one of the most important events related to Lysososomal Diseases, like Fabry, at an international level. The goal of WORLDSymposium is to provide an interdisciplinary forum to explore and discuss specific areas of interest, research and clinical applicability related to lysosomal diseases. Each year, WORLDSymposium hosts a scientific meeting presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases. Our approach for an innovative treatment was presented as an oral communication and as a poster, increasing impact and visibility. It is worthy to mention that it was the only communication related to the application of nanomedicine to lysosomal storage diseases, showing the high innovation potential that Smart4Fabry posses.
Researchers and clinicians working in the field of lysosomal disorders had the opportunity to put in common the most recent advances in the diagnosis, pathophysiology and management of lysosomal storage disorders in general and of Fabry Disease in particular. During the seminar celebrated in Barcelona on November 19th, patients also had the chance to discuss with administrators and professionals about their expectations and demands, as well as their the need for collaborative actions aiming at designing plans for early diagnosis and easy access to the most suitable therapies.
Genetic deficiencies of lysosomal components, most commonly enzymes, are known as “lysosomal storage disorders” (LSDs) and lead to lysosomal dysfunction, broadly affecting peripheral organs and the central nervous system, debilitating patients and frequently causing fatality. This seminar will update clinicians and researchers on most recent advances in diagnosis, pathophysiology and management of Fabry disease as well as in emerging therapies in the treatment of LSD. This seminar is supported by Smart4Fabry project.